| Item Type | Name |
|
Concept
|
Antidepressive Agents
|
|
Concept
|
Antiparkinson Agents
|
|
Concept
|
Ataxia
|
|
Concept
|
Australia
|
|
Concept
|
Alleles
|
|
Concept
|
Central Nervous System Agents
|
|
Concept
|
Amphetamine
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Base Sequence
|
|
Concept
|
Atrophy
|
|
Concept
|
Autoantibodies
|
|
Concept
|
Body Temperature
|
|
Concept
|
Cerebellum
|
|
Concept
|
Genes, Synthetic
|
|
Concept
|
Chorea
|
|
Concept
|
Drug Synergism
|
|
Concept
|
Electrodes, Implanted
|
|
Concept
|
Electric Countershock
|
|
Concept
|
Electrophoresis, Polyacrylamide Gel
|
|
Concept
|
Lac Operon
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Postural Balance
|
|
Concept
|
Estradiol
|
|
Concept
|
Deglutition Disorders
|
|
Concept
|
Exons
|
|
Concept
|
Cocaine
|
|
Concept
|
Corpus Striatum
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
Electron Transport Complex IV
|
|
Concept
|
DNA
|
|
Concept
|
Double-Blind Method
|
|
Concept
|
Drug Utilization
|
|
Concept
|
Fragile X Syndrome
|
|
Concept
|
Interferons
|
|
Concept
|
Microtubule-Associated Proteins
|
|
Concept
|
Gene Expression Regulation
|
|
Concept
|
Dystonia
|
|
Concept
|
Electroencephalography
|
|
Concept
|
p-Chloroamphetamine
|
|
Concept
|
Dopamine
|
|
Concept
|
Dyskinesia, Drug-Induced
|
|
Concept
|
Enzyme Induction
|
|
Concept
|
Formamides
|
|
Concept
|
Gait
|
|
Concept
|
Intracellular Fluid
|
|
Concept
|
Membrane Glycoproteins
|
|
Concept
|
Mice, Transgenic
|
|
Concept
|
Estrogens
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Molecular Sequence Data
|
|
Concept
|
Methamphetamine
|
|
Concept
|
Mutation
|
|
Concept
|
HeLa Cells
|
|
Concept
|
Patient Acceptance of Health Care
|
|
Concept
|
Practice Patterns, Physicians'
|
|
Concept
|
Polymorphism, Genetic
|
|
Concept
|
Olivopontocerebellar Atrophies
|
|
Concept
|
Protein Synthesis Inhibitors
|
|
Concept
|
Quality of Life
|
|
Concept
|
3,4-Methylenedioxyamphetamine
|
|
Concept
|
Cohort Studies
|
|
Concept
|
RNA Probes
|
|
Concept
|
RNA Splicing
|
|
Concept
|
Serotonin
|
|
Concept
|
Retinitis Pigmentosa
|
|
Concept
|
Saimiri
|
|
Concept
|
Humans
|
|
Concept
|
Tomography, Emission-Computed, Single-Photon
|
|
Concept
|
Tomography, X-Ray Computed
|
|
Concept
|
Tremor
|
|
Concept
|
Torticollis
|
|
Concept
|
Calcium Channels
|
|
Concept
|
Iodine Radioisotopes
|
|
Concept
|
Tyrosine 3-Monooxygenase
|
|
Concept
|
5,7-Dihydroxytryptamine
|
|
Concept
|
Gene Library
|
|
Concept
|
Drug Resistance, Neoplasm
|
|
Concept
|
Essential Tremor
|
|
Concept
|
Electrophoretic Mobility Shift Assay
|
|
Concept
|
Global Health
|
|
Concept
|
3,4-Dihydroxyphenylacetic Acid
|
|
Concept
|
Defibrillators, Implantable
|
|
Concept
|
Neurofilament Proteins
|
|
Concept
|
Comorbidity
|
|
Concept
|
Rats, Sprague-Dawley
|
|
Concept
|
Clinical Trials, Phase II as Topic
|
|
Concept
|
Drug Delivery Systems
|
|
Concept
|
Myoclonus
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Alternative Splicing
|
|
Concept
|
In Situ Hybridization
|
|
Concept
|
Sequence Analysis, DNA
|
|
Concept
|
Melatonin
|
|
Concept
|
Methionine
|
|
Concept
|
Genes, Reporter
|
|
Concept
|
tau Proteins
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
Gene Expression Regulation, Developmental
|
|
Concept
|
DNA, Complementary
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
Serotonin Plasma Membrane Transport Proteins
|
|
Concept
|
Subthalamic Nucleus
|
|
Concept
|
Cross-Over Studies
|
|
Concept
|
Neuroprotective Agents
|
|
Concept
|
Cyclic Nucleotide Phosphodiesterases, Type 6
|
|
Concept
|
Parkinson Disease
|
|
Concept
|
Consensus
|
|
Concept
|
Diffusion Magnetic Resonance Imaging
|
|
Concept
|
Positron-Emission Tomography
|
|
Concept
|
COS Cells
|
|
Concept
|
Response Elements
|
|
Concept
|
Gait Disorders, Neurologic
|
|
Concept
|
Trinucleotide Repeats
|
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
|
Concept
|
Nucleic Acid Synthesis Inhibitors
|
|
Concept
|
Spinocerebellar Ataxias
|
|
Concept
|
Gene Expression Profiling
|
|
Concept
|
Precipitin Tests
|
|
Concept
|
Promoter Regions, Genetic
|
|
Concept
|
Mice
|
|
Concept
|
Health Status Disparities
|
|
Concept
|
Rod Cell Outer Segment
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Supranuclear Palsy, Progressive
|
|
Concept
|
Dioxygenases
|
|
Concept
|
Cysteine Dioxygenase
|
|
Concept
|
Rats
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Concept
|
Temperature
|
|
Concept
|
Blotting, Western
|
|
Concept
|
Down-Regulation
|
|
Concept
|
1-Methyl-4-phenylpyridinium
|
|
Concept
|
Transcytosis
|
|
Concept
|
Death, Sudden, Cardiac
|
|
Concept
|
Blotting, Northern
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Polymerase Chain Reaction
|
|
Concept
|
Amyloid beta-Peptides
|
|
Concept
|
Hypokinesia
|
|
Concept
|
Dopamine Uptake Inhibitors
|
|
Concept
|
N-Methyl-3,4-methylenedioxyamphetamine
|
|
Concept
|
Clinical Trials, Phase III as Topic
|
|
Concept
|
Xenograft Model Antitumor Assays
|
|
Concept
|
Homeodomain Proteins
|
|
Concept
|
Statistics, Nonparametric
|
|
Concept
|
Deep Brain Stimulation
|
|
Concept
|
JNK Mitogen-Activated Protein Kinases
|
|
Concept
|
Genome-Wide Association Study
|
|
Concept
|
Tumor Microenvironment
|
|
Concept
|
Healthcare Disparities
|
|
Concept
|
Implantable Neurostimulators
|
|
Concept
|
Autopsy
|
|
Concept
|
Cell Survival
|
|
Concept
|
Intracranial Arteriovenous Malformations
|
|
Concept
|
Cloning, Molecular
|
|
Concept
|
Ethidium
|
|
Concept
|
Fenfluramine
|
|
Concept
|
Fluorescent Dyes
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Immunochemistry
|
|
Concept
|
Levodopa
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Magnetic Resonance Imaging
|
|
Concept
|
Mice, Mutant Strains
|
|
Concept
|
Models, Neurological
|
|
Concept
|
Nasopharyngeal Neoplasms
|
|
Concept
|
Neuroblastoma
|
|
Concept
|
Oxides
|
|
Concept
|
Papio
|
|
Concept
|
Phosphoric Diester Hydrolases
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Staining and Labeling
|
|
Concept
|
Databases, Factual
|
|
Concept
|
DNA Primers
|
|
Concept
|
Polymorphism, Single-Stranded Conformational
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
Genomics
|
|
Concept
|
MicroRNAs
|
|
Concept
|
Dopamine Plasma Membrane Transport Proteins
|
|
Concept
|
Patient Safety
|
|
Academic Article
|
Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD.
|
|
Academic Article
|
Respiratory dyskinesia in a patient with Parkinson disease successfully treated with STN DBS.
|
|
Academic Article
|
The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort.
|
|
Academic Article
|
Clinical and demographic characteristics related to onset site and spread of cervical dystonia.
|
|
Academic Article
|
Comments on the recent viewpoint article on low-frequency deep brain stimulation for Parkinson's disease.
|
|
Academic Article
|
Anticholinergic responsive cyclic myoclonus.
|
|
Academic Article
|
Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.
|
|
Academic Article
|
Human catechol-O-methyltransferase down-regulation by estradiol.
|
|
Academic Article
|
A murine dopamine neuron-specific cDNA library and microarray: increased COX1 expression during methamphetamine neurotoxicity.
|
|
Academic Article
|
Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription.
|
|
Academic Article
|
Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates.
|
|
Academic Article
|
Catechol-O-methyltransferase inhibitors in Parkinson's disease.
|
|
Academic Article
|
Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.
|
|
Academic Article
|
G/A1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease.
|
|
Academic Article
|
Identification and characterization of metallothionein-1 and -2 gene expression in the context of (+/-)3,4-methylenedioxymethamphetamine-induced toxicity to brain dopaminergic neurons.
|
|
Academic Article
|
Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity.
|
|
Academic Article
|
Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity.
|
|
Academic Article
|
Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial.
|
|
Academic Article
|
Consensus Paper: Experimental Neurostimulation of the Cerebellum.
|
|
Academic Article
|
Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.
|
|
Academic Article
|
Using global team science to identify genetic parkinson's disease worldwide.
|
|
Academic Article
|
Motor phenotype classification in moderate to advanced PD in BioFIND study.
|
|
Academic Article
|
Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in Parkinsonism.
|
|
Academic Article
|
Disability-inclusive compassionate care: Disability competencies for an Indian Medical Graduate.
|
|
Academic Article
|
Interference of subcutaneous implantable cardioverter defibrillator by deep brain stimulation.
|
|
Academic Article
|
Impact of oral textures on aspiration and changes in swallow dynamics in patients with PD with DBS.
|
|
Academic Article
|
Deep Brain Stimulation Impedance Decreases Over Time Even When Stimulation Settings Are Held Constant.
|
|
Academic Article
|
Effect of Deep Brain Stimulation on Swallowing Function: A Systematic Review.
|
|
Academic Article
|
Disease course and treatment patterns in progressive supranuclear palsy: A real-world study.
|
|
Academic Article
|
Disparities in diagnosis, treatment and survival between Black and White Parkinson patients.
|
|
Academic Article
|
Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care.
|
|
Academic Article
|
Position-Related Paroxysmal Facial Twitching.
|
|
Academic Article
|
Severity of Downgaze Palsy in the Context of Disease Duration Could Estimate Survival Duration in Patients With Progressive Supranuclear Palsy.
|
|
Academic Article
|
Effect of Deep Brain Stimulation on Cerebellar Tremor Compared to Non-Cerebellar Tremor Using a Wearable Device in a Patient With Multiple Sclerosis: Case Report.
|
|
Academic Article
|
Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study.
|
|
Academic Article
|
N-Oxide polymer-cupric ion nanogels potentiate disulfiram for cancer therapy.
|
|
Academic Article
|
Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt/ß-catenin signaling pathway.
|
|
Academic Article
|
Corrigendum: The Tumor Suppressor Role of Zinc Finger Protein 671 (ZNF671) in Multiple Tumors Based on Cancer Single-Cell Sequencing.
|
|
Academic Article
|
The Tumor Suppressor Role of Zinc Finger Protein 671 (ZNF671) in Multiple Tumors Based on Cancer Single-Cell Sequencing.
|
|
Academic Article
|
Differential Expression and Alternative Splicing of Transcripts Associated With Cisplatin-Induced Chemoresistance in Nasopharyngeal Carcinoma.
|
|
Academic Article
|
Pan-Cancer Analysis of Genomic and Prognostic Characteristics Associated With Coronavirus Disease 2019 Regulators.
|
|
Academic Article
|
Symmetric Arginine Dimethylation Is Selectively Required for mRNA Splicing and the Initiation of Type I and Type III Interferon Signaling.
|
|
Academic Article
|
Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: The current status and transcytosis strategy.
|
|
Academic Article
|
Remotely Triggered Assembly of 3D Mesostructures Through Shape-Memory Effects.
|
|
Academic Article
|
Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study.
|
|
Academic Article
|
Pan-cancer analyses reveal genomics and clinical characteristics of the melatonergic regulators in cancer.
|
|
Academic Article
|
A Modified Progressive Supranuclear Palsy Rating Scale for Virtual Assessments.
|
|
Academic Article
|
Recommendations for Virtual Administration of the PSP Rating Scale.
|
|
Academic Article
|
Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.
|
|
Academic Article
|
Common Variants Near ZIC1 and ZIC4 in Autopsy-Confirmed Multiple System Atrophy.
|
|
Academic Article
|
Using Downgaze Palsy Progression Rate to Model Survival in Progressive Supranuclear Palsy-Richardson Syndrome.
|
|
Concept
|
Machine Learning
|
|
Concept
|
Administration, Intravenous
|
|
Concept
|
Catechol O-Methyltransferase Inhibitors
|
|
Academic Article
|
Early, Middle, and Late-Stage Progression Rates in Progressive Supranuclear palsy-Richardson Syndrome.
|
|
Academic Article
|
Cognitive outcomes in patients with essential tremor treated with deep brain stimulation: a systematic review.
|